Gellan Film as an Implant for Insulin Delivery

Abstract

Gellan gum is an anionic polysaccharide produced by the aerobic fermentation of Pseudomonas elodea in batch culture. Gellan undergoes calcium-induced cross-linking to form a three-dimensional network, and this property makes it particularly attractive for the incorporation of biological moieties such as proteins. In this study, a procedure for the preparation of gellan films was developed and optimized, and the characteristics of these films were investigated. In addition, the effects of the concentration of each ingredient in gellan films and in vitro release behavior of fluorescein isothiocyanate dextran from these films was examined.

This film device was implanted for insulin delivery in diabetic rats. The blood glucose levels of the diabetic rats implanted with insulin-loaded films were about half of those implanted with blank films, and this therapeutic effect of insulin could last for one week. Both in vitro and in vivo studies indicated that the gellan film could be an ideal candidate in the development of protein delivery systems.

Keywords

gellan implant insulin delivery

Get full access to this article

View all access options for this article.

References

1. Sanders, L.M. 1990. “Drug delivery systems and routes of administration of peptide and protein drugs”, Europea J. Drug Metab. Pharmacok., 15(2): 95–102.

2. Bai, J.P. 1993. “Comparison of site-dependent degradation of peptide drugs within the gut of rats and rabbits”, J. Pharm.Pharmacol., 45: 1085–1087.

3. Golomb, G. , Shaked, I. and Hoffman, A. 1995. “Intrauterine administration of peptide drugs for systemic effect”, Adv. Drug Delivery Rev., 17: 179–190.

4. Eppstein, D.A. and Longenecker, J.P. 1988. “Alternative delivery systems for peptides and proteins as drugs”, Therep. Drug. Carr. Syst., 5(2): 99–135.

5. Langer, R. and Peppas, N.A. 1981. “Present and future applications of biomaterials in controlled drug delivery systems”, Biomat., 2: 201–214.

6. Heller, J. 1993. “Polymers for controlled parenteral delivery of peptides and proteins”, Adv. Drug Delivery Rev., 10(2/3): 163–204.

7. Pitt, C.G. 1990. “The controlled parenteral delivery of polypeptides and proteins”, Int. J. Pharm., 59: 173–196.

8. Mackay, M. 1990. “Delivery of recombinant peptide and protein drugs”, Biotech. Genet. Eng. Rev., 8: 251–278.

9. Kang, K.S. , Veeder, G.T. and Cottrell, I.W. 1983. “Gellan gum, a new polysaccharide”, Prog. Indust. Microbiol., 18: 231–253.

10.

10. Moritaka, H. , Fukuba, H. , Kumeno, K. , Nakahama, N. and Nishinari, K. 1991. “Effect of monovalent and divalent cations of the rheological properties of gellan gels”, Food Hydrocoll., 4(6): 495–507.

11.

11. Sanderson, G.R. 1990. “Gellan gum.” in: Food gels. Harris, P. , (ed.), Elsevier Applied Science. London and New York, pp. 201–233.

12.

12. Duxbury, D.D. 1993. “Fat reduction without adding fat reducers”, Food Process., 3: 68–69.

13.

13. Anonymous . 1992. “Food additives permitted for direct addition to food for human consumption: Gellan gum”, Fedl. Register, 57(228): 55444–55445.

14.

14. Rozier, A. , Mazuel, C. , Grove, J. and Plaronner, B. 1989. “Gelrite: a novel, ion-activated, in situ gelling polymer for ophthalmic vehicles: Effect on bioavailability of timolol”, Int. J. Pharm., 57: 163–168.

15.

15. Sanzgiri, Y.D. , Maschi, V. and Crescenzi, L. 1993. “Gellan-based system for ophthalmic sustained delivery of methylprednisolone”, J. Contrl. Rel., 26: 195–201.

16.

16. Simon, B. 1992. “Structure and rheology of gelatin gels: recent progress”, Polymer, 33(12): 2622–2627.

17.

17. Kamath, K.R. and Park, K. 1993. “Biodegradable hydrogels in drug delivery”, Adv. Drug Delivery Rev., 11: 59–84.